Cost effectiveness of preventive home visits to the elderly: economic evaluation alongside randomized controlled study.

Cost effectiveness of preventive home visits to the elderly: economic evaluation alongside randomized controlled study.
复制标题

DOI:
10.1007/s10198-006-0361-2
复制
发表时间:
2006-12-01
期刊:
The European journal of health economics : HEPAC : health economics in prevention and care
影响因子:
--
通讯作者:
Avlund, Kirsten
Avlund, Kirsten
中科院分区:
其他
文献类型:
--
作者:
Kronborg, Christian;Vass, Mikkel;Avlund, Kirsten

文献摘要

被引文献

相似文献

我们评估了丹麦老年人预防性家访的成本效益以及一项为期3年的随机对照研究。主要的结果衡量指标是每活跃生命年增加的成本。活跃生命年的定义是指一个人能够独立移动,在室内行走,在室外行走,在宜人和恶劣的天气下在室外行走,爬楼梯。在34个城市中,有17个城市向保健巡视员和全科医生提供了老年病学培训,重点是残疾的早期迹象、身体活动和跨学科后续行动。其余17个市照常提供预防性家访。研究人员对4034名年龄在75岁或80岁、住在家里的人进行了调查。干预组和对照组在3%折扣下的平均总成本差异75岁为-856欧元(95% CI - 2455 - 744), 80岁为694欧元(- 2684 - 4071)。平均活动寿命年折现差分别为0.034(-0.058 ~ 0.125)和0.197(0.013 ~ 0.380)。这项研究并没有就所考虑的项目的成本效益提供确凿的证据。
We evaluated the cost effectiveness of preventive home visits to elderly persons in Denmark alongside a 3-year randomized controlled study. The main outcome measure was incremental costs per active life-year gained. The number of active life-years was defined as those during which the person is able independently to transfer, walk indoors, go outdoors, walk outdoors in both pleasant and poor weather, and climb stairs. In 17 of 34 municipalities health visitors and general practitioners were offered geriatric training, which focused on early signs of disability, physical activity, and interdisciplinary follow-up. The remaining 17 municipalities offered preventive home visits as usual. Outcomes were measured in 4,034 persons aged 75 or 80 years old and dwelling at home. The difference in mean total costs between the intervention and the control group discounted at 3% was -856 euro (95% CI -2,455 to 744) in 75-year-olds and 694 euro (-2,684 to 4,071) in 80-year-olds. The discounted difference in mean active life-years was 0.034 (-0.058 to 0.125) and 0.197 (0.013 to 0.380), respectively. The study did not provide conclusive evidence on the cost effectiveness of the programs under consideration.